A Two-Part Mixture Model for Longitudinal Adverse Event Severity Data
暂无分享,去创建一个
Lynn McFadyen | Kenneth G. Kowalski | Matthew M. Hutmacher | Bill Frame | Raymond Miller | M. Hutmacher | K. Kowalski | B. Frame | L. Mcfadyen | Raymond Miller
[1] J. Hinde,et al. A Score Test for Testing a Zero‐Inflated Poisson Regression Model Against Zero‐Inflated Negative Binomial Alternatives , 2001, Biometrics.
[2] V. Farewell,et al. The use of mixture models for the analysis of survival data with long-term survivors. , 1982, Biometrics.
[3] L B Sheiner,et al. Quantitative characterization of therapeutic index: Application of mixed‐effects modeling to evaluate oxybutynin dose–efficacy and dose–side effect relationships , 1999, Clinical pharmacology and therapeutics.
[4] Diane Lambert,et al. Zero-inflacted Poisson regression, with an application to defects in manufacturing , 1992 .
[5] D R Stanski,et al. Population pharmacodynamic model for ketorolac analgesia , 1996, Clinical pharmacology and therapeutics.
[6] M. Hutmacher,et al. Efficient Screening of Covariates in Population Models Using Wald's Approximation to the Likelihood Ratio Test , 2001, Journal of Pharmacokinetics and Pharmacodynamics.
[7] Roderick J. A. Little,et al. Modeling the Drop-Out Mechanism in Repeated-Measures Studies , 1995 .
[8] J G Ibrahim,et al. Maximum Likelihood Methods for Cure Rate Models with Missing Covariates , 2001, Biometrics.
[9] G. Schwarz. Estimating the Dimension of a Model , 1978 .
[10] Joseph L Schafer,et al. A Two-Part Random-Effects Model for Semicontinuous Longitudinal Data , 2001 .
[11] Robert V. Hogg,et al. Introduction to Mathematical Statistics. , 1966 .
[12] Adrian Dunne,et al. Analysis of Nonrandomly Censored Ordered Categorical Longitudinal Data from Analgesic Trials , 1997 .
[13] L B Sheiner,et al. A new approach to the analysis of analgesic drug trials, illustrated with bromfenac data , 1994, Clinical pharmacology and therapeutics.
[14] David C. Heilbron,et al. Zero-Altered and other Regression Models for Count Data with Added Zeros , 1994 .
[15] Gordon Graham,et al. Determination of an Optimal Dosage Regimen Using a Bayesian Decision Analysis of Efficacy and Adverse Effect Data , 2002, Journal of Pharmacokinetics and Pharmacodynamics.